BB&T Securities LLC decreased its position in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 8.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 24,379 shares of the financial services provider’s stock after selling 2,325 shares during the quarter. BB&T Securities LLC’s holdings in iShares Nasdaq Biotechnology ETF were worth $2,350,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Albion Financial Group UT raised its stake in iShares Nasdaq Biotechnology ETF by 1.3% in the fourth quarter. Albion Financial Group UT now owns 101,575 shares of the financial services provider’s stock valued at $9,795,000 after purchasing an additional 1,273 shares in the last quarter. Smith Moore & CO. grew its stake in shares of iShares Nasdaq Biotechnology ETF by 29.3% during the 3rd quarter. Smith Moore & CO. now owns 5,724 shares of the financial services provider’s stock valued at $698,000 after acquiring an additional 1,296 shares during the period. Simplex Trading LLC bought a new position in shares of iShares Nasdaq Biotechnology ETF during the 4th quarter valued at approximately $792,000. Virtu Financial LLC purchased a new position in iShares Nasdaq Biotechnology ETF in the 4th quarter worth approximately $1,191,000. Finally, Lido Advisors LLC raised its holdings in shares of iShares Nasdaq Biotechnology ETF by 25.9% during the 3rd quarter. Lido Advisors LLC now owns 4,256 shares of the financial services provider’s stock worth $519,000 after acquiring an additional 875 shares in the last quarter. Hedge funds and other institutional investors own 66.51% of the company’s stock.
NASDAQ:IBB opened at $109.75 on Thursday. iShares Nasdaq Biotechnology ETF has a fifty-two week low of $89.01 and a fifty-two week high of $122.97.
TRADEMARK VIOLATION NOTICE: “BB&T Securities LLC Lowers Holdings in iShares Nasdaq Biotechnology ETF (IBB)” was reported by American Banking News and is the sole property of of American Banking News. If you are viewing this news story on another website, it was stolen and reposted in violation of US & international copyright and trademark legislation. The legal version of this news story can be accessed at https://www.americanbankingnews.com/2019/02/14/bbt-securities-llc-lowers-holdings-in-ishares-nasdaq-biotechnology-etf-ibb.html.
About iShares Nasdaq Biotechnology ETF
iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.
See Also: What factors cause inflation to rise?
Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.